Cargando…
The Effect of the 5-HT(4) Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain
Depression is a common and often recurrent illness with significant negative impact on a global scale. Current antidepressants are ineffective for up to one third of people with depression, many of whom experience persistent symptomatology. 5-HT(4) receptor agonists show promise in both animal model...
Autores principales: | de Cates, Angharad N., Martens, Marieke A. G., Wright, Lucy C., Gould van Praag, Cassandra D., Capitão, Liliana P., Gibson, Daisy, Cowen, Philip J., Harmer, Catherine J., Murphy, Susannah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039209/ https://www.ncbi.nlm.nih.gov/pubmed/35492722 http://dx.doi.org/10.3389/fpsyt.2022.859123 |
Ejemplares similares
-
Déjà-vu? Neural and behavioural effects of the 5-HT(4) receptor agonist, prucalopride, in a hippocampal-dependent memory task
por: de Cates, Angharad N., et al.
Publicado: (2021) -
Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021) -
Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation
por: Wong, Banny S, et al.
Publicado: (2010) -
Radiosynthesis and preclinical evaluation of [(11)C]prucalopride as a potential agonist PET ligand for the 5-HT(4) receptor
por: Buiter, Hans JC, et al.
Publicado: (2013) -
Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons
por: Stakenborg, Nathalie, et al.
Publicado: (2019)